Edwards Lifesciences Reports Fourth Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Edwards Lifesciences (EW) PT Raised to $186 at Raymond James
February 1, 2019 7:47 AM ESTRaymond James analyst Jayson Bedford raised the price target on Edwards Lifesciences (NYSE: EW) to $186.00 (from $175.00) while maintaining a Outperform rating.
... MoreEdwards Lifesciences (EW) PT Raised to $175 at UBS
February 1, 2019 7:15 AM ESTUBS analyst Matthew Taylor raised the price target on Edwards Lifesciences (NYSE: EW) to $175.00 (from $165.00) while maintaining a Neutral rating.
... MoreEdwards Lifesciences (EW) PT Raised to $182 at RBC Capital
February 1, 2019 6:42 AM ESTRBC Capital analyst Glenn Novarro raised the price target on Edwards Lifesciences (NYSE: EW) to $182.00 (from $175.00) while maintaining a Outperform rating.
Novarro commented, "Revenue guidance for 1Q19, implying high-single-digit CC growth at the midpoint, adequately captures competitive dynamics in the TAVR market.... More
Edwards Lifesciences (EW) Reports In-Line Q4 EPS, Q1 EPS Guidance Comes in Light
January 31, 2019 4:19 PM ESTEdwards Lifesciences (NYSE: EW) reported Q4 EPS of $1.17, in-line with the analyst estimate of $1.17. Revenue for the quarter came in at $978 million versus the consensus estimate of $975.92 million.
GUIDANCE:
Edwards Lifesciences sees Q1 2019 EPS of $1.15-$1.25, versus the consensus of $1.30.... More
